NATURAL OCCURRENCE OF DRUG-RESISTANCE MUTATIONS IN THE REVERSE-TRANSCRIPTASE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES

被引:78
作者
NAJERA, I
RICHMAN, DD
OLIVARES, I
ROJAS, JM
PEINADO, MA
PERUCHO, M
NAJERA, R
LOPEZGALINDEZ, C
机构
[1] INST SALUD CARLOS 3,CTR NACL BIOL CELULAR & RETROVIRUS,E-28220 MADRID,SPAIN
[2] CALIF INST BIOL RES,LA JOLLA,CA 92037
[3] UNIV CALIF SAN DIEGO,DEPT PATHOL,LA JOLLA,CA 92093
[4] UNIV CALIF SAN DIEGO,DEPT MED 0679-9500,LA JOLLA,CA 92093
[5] WELLCOME RES LABS,BECKENHAM BR3 3BS,KENT,ENGLAND
关键词
D O I
10.1089/aid.1994.10.1479
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Reverse transcriptase-associated amino acid substitutions related to ddC, d4T, and nevirapine resistance have been found in isolates of human immunodeficiency virus type 1 (HIV-1) from patients treated with AZT only. Sequence analysis of 23 isolates documented the presence of 4 unexpected mutations at amino acid residues related to drug resistance. Two isolates contained an aspartic residue in codon 69 associated with ddC resistance, and another a change in codon 75 associated with resistance to d4T. The Y-to-C alteration in codon 181 associated with nevirapine resistance was observed in another isolate after serial passage in cell culture in the absence of drug. Changes in substitution patterns were also noted after serial passage of four AZT resistant isolates in cell culture without inhibitors. One of the strains showed changes in codons 67 and 70 to wild-type residues. Clonal analysis showed that this alteration occurred by the selection during cell culture passage of the wild-type genotype, which was present as a minority subpopulation in the initially resistant virus stock, rather than to genetic reversion. In summary, we present evidence documenting the presence of mutations associated with drug resistance in the absence of drug treatment and supporting the role played by genetic variability in the emergence of HIV-1 antiviral resistance.
引用
收藏
页码:1479 / 1488
页数:10
相关论文
共 40 条
  • [1] ORDERED APPEARANCE OF ZIDOVUDINE RESISTANCE MUTATIONS DURING TREATMENT OF 18 HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE SUBJECTS
    BOUCHER, CAB
    OSULLIVAN, E
    MULDER, JW
    RAMAUTARSING, C
    KELLAM, P
    DARBY, G
    LANGE, JMA
    GOUDSMIT, J
    LARDER, BA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (01) : 105 - 110
  • [2] EFFECTS OF DISCONTINUATION OF ZIDOVUDINE TREATMENT ON ZIDOVUDINE SENSITIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES
    BOUCHER, CAB
    VANLEEUWEN, R
    KELLAM, P
    SCHIPPER, P
    TIJNAGEL, J
    LANGE, JMA
    LARDER, BA
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (07) : 1525 - 1530
  • [3] 2',3'-DIDEHYDRO-3'-DEOXYTHYMIDINE (D4T) IN PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX - A PHASE-I TRIAL
    BROWNE, MJ
    MAYER, KH
    CHAFEE, SBD
    DUDLEY, MN
    POSNER, MR
    STEINBERG, SM
    GRAHAM, KK
    GELETKO, SM
    ZINNER, SH
    DENMAN, SL
    DUNKLE, LM
    KAUL, S
    MCLAREN, C
    SKOWRON, G
    KOUTTAB, NM
    KENNEDY, TA
    WEITBERG, AB
    CURT, GA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (01) : 21 - 29
  • [4] HIV-1-SPECIFIC RT INHIBITORS - HIGHLY SELECTIVE INHIBITORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 THAT ARE SPECIFICALLY TARGETED AT THE VIRAL REVERSE-TRANSCRIPTASE
    DECLERCQ, E
    [J]. MEDICINAL RESEARCH REVIEWS, 1993, 13 (03) : 229 - 258
  • [5] THE QUASISPECIES (EXTREMELY HETEROGENEOUS) NATURE OF VIRAL-RNA GENOME POPULATIONS - BIOLOGICAL RELEVANCE - A REVIEW
    DOMINGO, E
    MARTINEZSALAS, E
    SOBRINO, F
    DELATORRE, JC
    PORTELA, A
    ORTIN, J
    LOPEZGALINDEZ, C
    PEREZBRENA, P
    VILLANUEVA, N
    NAJERA, R
    VANDEPOL, S
    STEINHAUER, D
    DEPOLO, N
    HOLLAND, J
    [J]. GENE, 1985, 40 (01) : 1 - 8
  • [6] EIGEN M, 1988, RNA GENETICS, P211
  • [7] HIV AND MULTIDRUG-RESISTANCE
    EMINI, EA
    GRAHAM, DJ
    GOTLIB, L
    CONDRA, JH
    BYRNES, VW
    SCHLEIF, WA
    [J]. NATURE, 1993, 364 (6439) : 679 - 679
  • [8] THE EFFICACY OF AZIDOTHYMIDINE (AZT) IN THE TREATMENT OF PATIENTS WITH AIDS AND AIDS-RELATED COMPLEX - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    FISCHL, MA
    RICHMAN, DD
    GRIECO, MH
    GOTTLIEB, MS
    VOLBERDING, PA
    LASKIN, OL
    LEEDOM, JM
    GROOPMAN, JE
    MILDVAN, D
    SCHOOLEY, RT
    JACKSON, GG
    DURACK, DT
    KING, D
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (04) : 185 - 191
  • [9] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 POL GENE-MUTATIONS WHICH CAUSE DECREASED SUSCEPTIBILITY TO 2',3'-DIDEOXYCYTIDINE
    FITZGIBBON, JE
    HOWELL, RM
    HABERZETTL, CA
    SPERBER, SJ
    GOCKE, DJ
    DUBIN, DT
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (01) : 153 - 157
  • [10] USE OF SELF-SUSTAINED SEQUENCE REPLICATION AMPLIFICATION REACTION TO ANALYZE AND DETECT MUTATIONS IN ZIDOVUDINE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS
    GINGERAS, TR
    PRODANOVICH, P
    LATIMER, T
    GUATELLI, JC
    RICHMAN, DD
    BARRINGER, KJ
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (06) : 1066 - 1074